Fortis Healthcare Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors considered and approved these results, along with the limited review report from the statutory auditors. The company also provided updates on various ongoing investigations and legal matters.
Fortis Healthcare Announces Quarterly Financial Results
Fortis Healthcare Limited has officially announced the approval of its unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The Board of Directors convened a meeting on November 5, 2026, to review and approve these financial statements, which were prepared in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Financial Highlights
The financial results indicate a revenue from operations of ₹51,941 lacs for the standalone quarter ended September 30, 2026, and ₹273,483 lacs on a consolidated basis. The net profit for the quarter stood at ₹12,991 lacs on a standalone basis and ₹32,047 lacs on a consolidated basis. The company also reported Total Comprehensive Income of ₹13,142 lacs (standalone) and ₹32,874 lacs (consolidated) for the same period.
Auditor’s Report and Compliance
The accompanying limited review report from BSR & Co. LLP, Chartered Accountants, confirms that based on their review, nothing has come to their attention that causes them to believe that the accompanying financial statements are not in accordance with the prescribed Indian Accounting Standards and other accounting principles generally accepted in India. The report also highlights certain ongoing investigations and legal matters that the company is involved in, noting that provisions have been made where applicable and management believes the impact is not material.
Operational and Legal Updates
The company’s filing also includes extensive details on various legal proceedings and investigations, including those related to the Serious Fraud Investigation Office (SFIO), Economic Offences Wing (EOW), and regulatory authorities like SEBI and the Registrar of Companies. Management has indicated that while these matters are ongoing, provisions have been made for potential contingencies, and they believe the likelihood of additional material impact is low.
Further details regarding exceptional gains/losses, segment reporting, and financial covenants are also provided within the comprehensive disclosure.
Source: BSE
